Effects of high dose telmisartan or combination telmisartan/amlodipine on albuminuria in patients with hypertension and type 2 diabetes

Effects of high dose telmisartan or combination telmisartan/amlodipine on albuminuria in patients with hypertension and type 2 diabetes - Effects of high dose telmisartan or combInation telmisartan/amlodipine on albuminuria in patients with hypertension and type 2 diabetes.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006520

Enrollment

Registered

2011-10-15

Start date

2011-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Microalbuminuria in patients with diabetes and hypertension

Interventions

Telmisartan 80mg Telmisartan 40mg plus amlodipine 5mg

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.20 years of age or more 2.Diabetse with hypertension 3.Microalbuminuria 4.Under treatment with ARB 5.Patients with informed consent of this study

Exclusion criteria

Exclusion criteria: 1.Patients with history of hypersensitivity to telmisartan or amlodipine 2.Patients with acute or chronic renal failure 3.Patients on dialysis 4.Patients who are pregnant, possibly lactating or pregnant 5.Patients with hyperkalemia

Design outcomes

Primary

Measure	Time frame
Changes in the level of microalbuminuria	—

Secondary

Measure	Time frame
1.Blood pressure measured at home 2. Changes in the level of cholesterol profile.	—

Countries

Japan

Contacts

Public ContactSeigo Itoh

Juntendo University School of Medicine Department Cardiovascular Medicine

03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026